Epidermal growth factor receptor (EGFR) is a common driver gene in NSCLC, and approximately 20% of NSCLC patients have activating mutations in EGFR, particularly those who have an adenocarcinoma histology and have never smoked or have a history of light smoking [3]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.